Mariamena Arbitrio
Mariamena Arbitrio
Ricercatore Istituto Per la Ricerca ed Innovazione Biomedica-CNR Sede di Farmacologia Catanzaro
Email verificata su
Citata da
Citata da
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
MR Pitari, M Rossi, N Amodio, C Botta, E Morelli, C Federico, A GullÓ, ...
Oncotarget 6 (29), 27343, 2015
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMETá…
MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ...
Cancer biology & therapy 12 (9), 780-787, 2011
In vivo anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor
P Neri, P Tagliaferri, MT Di Martino, T Calimeri, N Amodio, A Bulotta, ...
British journal of haematology 143 (4), 520-531, 2008
DMET-analyzer: automatic analysis of Affymetrix DMET data
PH Guzzi, G Agapito, MT Di Martino, M Arbitrio, P Tassone, P Tagliaferri, ...
BMC bioinformatics 13 (1), 1-10, 2012
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?
I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ...
Journal of Drug Delivery 2013, 2013
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis
M Arbitrio, MT Di Martino, V Barbieri, G Agapito, PH Guzzi, C Botta, ...
Cancer chemotherapy and pharmacology 77 (1), 205-209, 2016
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patientsá…
MT Di Martino, M Arbitrio, PH Guzzi, E Leone, F Baudi, E Piro, T Prantera, ...
British journal of haematology 154 (4), 529, 2011
DMET™(Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine
M Arbitrio, MT Di Martino, F Scionti, G Agapito, PH Guzzi, M Cannataro, ...
Oncotarget 7 (33), 54028, 2016
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma
MA Stamato, G Juli, E Romeo, D Ronchetti, M Arbitrio, D Caracciolo, ...
Oncotarget 8 (63), 106527, 2017
Mouse models of multiple myeloma: technologic platforms and perspectives
M Rossi, C Botta, M Arbitrio, RD Grembiale, P Tagliaferri, P Tassone
Oncotarget 9 (28), 20119, 2018
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
MEG Cantafio, BS Nielsen, C Mignogna, M Arbitrio, C Botta, NM Frandsen, ...
Molecular Therapy-Nucleic Acids 5, e326, 2016
Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms
G Nisticˇ, MC Caroleo, M Arbitrio, L Pulvirenti
Neuroimmunomodulation 1 (3), 174-180, 1994
Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and bloodá…
D Frasca, F Guidi, M Arbitrio, C Pioli, F Poccia, R Cicconi, G Doria
Bone marrow transplantation 25 (4), 427-433, 2000
miR-22 suppresses DNA ligase III addiction in multiple myeloma
D Caracciolo, MT Di Martino, N Amodio, E Morelli, M Montesano, C Botta, ...
Leukemia 33 (2), 487-498, 2019
From single level analysis to multi-omics integrative approaches: a powerful strategy towards the precision oncology
ME Gallo Cantafio, K Grillone, D Caracciolo, F Scionti, M Arbitrio, ...
High-throughput 7 (4), 33, 2018
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
P Tagliaferri, M Ventura, F Baudi, I Cucinotto, M Arbitrio, MT Di Martino, ...
Journal of ovarian research 2 (1), 1-9, 2009
IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation
D Frasca, C Pioll, F Guidi, S Pucci, M Arbitrio, G Later, G Doria
International immunology 8 (11), 1651-1657, 1996
A reappraisal of the role of the various opioid receptor subtypes in cell-mediated immunity
MC Caroleo, M Arbitrio, D Melchiorri, G Nistic˛
Neuroimmunomodulation 1 (2), 141-147, 1994
Genetic variants associated with gastrointestinal symptoms in Fabry disease
MT Di Martino, F Scionti, S Sestito, A Nicoletti, M Arbitrio, PH Guzzi, ...
Oncotarget 7 (52), 85895, 2016
miRNAs and lncRNAs as novel therapeutic targets to improve cancer immunotherapy
MT Di Martino, C Riillo, F Scionti, K Grillone, N PolerÓ, D Caracciolo, ...
Cancers 13 (7), 1587, 2021
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20